<DOC>
	<DOCNO>NCT01510093</DOCNO>
	<brief_summary>This exploratory trial two cross-over arm investigate pharmacokinetic profile endogenous exogenous insulin type 2 diabetes mellitus patient treat continuous subcutaneous Insulin Aspart infusion combine without intravenous glucose infusion . The order treatment session randomise . Hypotheses : 1 . Secretion endogenous insulin depend exogenous insulin supply 2 . Secretion endogenous insulin depend plasma glucose level</brief_summary>
	<brief_title>Diurnal Variation Exogenous Peptides ( Endogenous Insulin Jurgita II )</brief_title>
	<detailed_description>There screen visit two treatment session : Session A : Treatment Insulin Aspart 1.5 IE/time overnight without intravenous glucose infusion Session B : Treatment Insulin Aspart 1.5 IE/time overnight intravenous glucose infusion .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Subjects type 2 diabetes mellitus Insulinnaive patient HbA1C &lt; 9 % Women men &gt; = 35 &lt; = 75 year old BMI 2542 kg/m2 , value include Suspected known allergy trial drug similar medication Treatment hte drug Investigator judgment could potentially interfere plasma glucose level Heart : Unstable angina pectoris , acute myocardial infarction within last 12 month Severe uncontrolled hypertension blood pressure lie position &gt; 180/110 mmHg Impaired liver function liver parameter 2 time upper normal limit accord local laboratory Impaired kidney function eGFR &lt; 50 ml/min accord local laboratory Pregnancy , lactation desire pregnancy study period woman childbearing age without adequate contraceptionadequate contraception : sterilisation , hysterectomy current use contraceptive pill , coil , gestagen depot injection , subdermal implantation , hormonal vaginal ring transdermal depot patch .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>type 2 diabetes mellitus , endogenous insulin</keyword>
</DOC>